基本信息
浏览量:206
职业迁徙
个人简介
Dr. Lasky-Su has been a leader in applying metabolomics research to epidemiology, covering a range of chronic diseases over the life course, with a focus on respiratory outcomes (e.g. asthma). Much of her work has focused on “integrative metabolomics” - the integration of other omics with using a metabolomic-centric perspective to study complex diseases. With integrative metabolomics as an emerging field, Dr. Lasky’s scholarship has contributed broadly, with peer-reviewed publications that focus on a range of disease outcomes (cancers, respiratory, ocular, infections, metabolic, neurodevelopment/mental health) and exposures (air pollutants, PFAS, nutrition, exercise) that may have an impact on health over the life course. Her investigative success is also demonstrated with >225 peer-reviewed publications. To date, she has been invited to give > 40 national and international talks. Dr. Lasky-Su has recently expanded her focus to study multiomics over the life course in the context of aging using the Mass General Brigham (MGB-Biobank), where she has generated a large, curated biobank cohort with multiomic data. As the most recent past president of the Metabolomics Society – the largest metabolomics society in the world – and the chairman of the NIH’s Consortium of Metabolomics Studies (COMETS) consortium – the largest international consortium of prospective metabolomics cohorts – over the past four years, her leadership in this area is unparalleled. She has also spearheaded new efforts, including initiating STROBE-metabolomics to provide reporting guidelines in this area and the Metabolomic Epidemiology Task Group to define and formalize this emerging field of study. In addition, Dr. Lasky-Su has extensive funding in multiomics; she is the PI/MPI of 4 current NIH R01s in metabolomics, the PI on multiple private grants, and the Consortium PI several R/U NIH grants. Her success is also reflected in the success of her mentees and co-mentees who have received K grants and gone on to have successful research careers, with some achieving a rank as high as full professor.
研究兴趣
论文共 67 篇作者统计合作学者相似作者
按年份排序按引用量排序主题筛选期刊级别筛选合作者筛选合作机构筛选
时间
引用量
主题
期刊级别
合作者
合作机构
D28 PEDIATRIC PULMONOLOGY BENCH-TO-BEDSIDE GENETICS, WHOLE-EXOME SEQUENCING, AND OMICS (2024)
B74 BREATHING NEW LIFE LUNG TRANSPLANT PATHOGENESIS AND MECHANISMS (2024)
Sofina Begum, Nicole Prince,Lidia Minguez-Alarcon,Yulu Chen,Djora I. Soeteman, Vrushali Fangal,Mengna Huang,Craig Wheelock,Kevin Mendez,Augusto A. Litonjua,Scott T. Weiss,Jessica Lasky-Su,Rachel S. Kelly
ENVIRONMENTAL SCIENCE-ADVANCES (2024)
Kevin M. Mendez,Sofina Begum,Anshul Tiwari,Rinku Sharma,Qingwen Chen,Rachel S. Kelly,Nicole Prince,Mengna Huang,Priyadarshini Kachroo,Su H. Chu,Yulu Chen,Kathleen Lee-Sarwar,David I. Broadhurst,Stacey N. Reinke, Robert Gerson,Clary Clish,Lydiana Avila,Juan C. Celedon,Craig E. Wheelock,Scott T. Weiss,Michael McGeachie,Jessica A. Lasky-Sua
EBioMedicine (2024): 105025-105025
Jennifer Styles,Sarita Patil,Bert Ruiter,Neal Smith,Clary Clish,Jessica Lasky-Su,Wayne Shreffler,Yamini Virkud
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGYno. 2 (2024): AB234-AB234
D.T. Tran, Y. Chen, L.G. Ramirez,J.A. Lasky-Su,A.C. Wu,K.G. Tantisira,M. Mcgeachie,S.T. Weiss,A. Dahlin
A34 LATE BREAKING ABSTRACTS IN ASTHMA AND ALLERGIC INFLAMMATION (2024)
R. Sharma, S. Begum,K. Mendez,J.C. Celedon,C. Clish,S.T. Weiss,K.G. Tantisira,J. Lasky-Su,M. Mcgeachie
D21 TERMINATOR CONTROL OF AIRWAY INFLAMMATION AND IMMUNE RESPONSE IN ASTHMA (2024)
D. T. Tran, Y. Chen,J. Hecker,D. B. Hawcutt,M. Pirmohamed,J. A. Lasky-Su,A. C. Wu,K. Tantisira,M. Mcgeachie,S. T. Weiss,A. Dahlin
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2023)
The journal of allergy and clinical immunology/Journal of allergy and clinical immunology/The journal of allergy and clinical immunologyno. 2 (2023): AB232-AB232
加载更多
作者统计
#Papers: 66
#Citation: 685
H-Index: 12
G-Index: 22
Sociability: 6
Diversity: 2
Activity: 22
合作学者
合作机构
D-Core
- 合作者
- 学生
- 导师
数据免责声明
页面数据均来自互联网公开来源、合作出版商和通过AI技术自动分析结果,我们不对页面数据的有效性、准确性、正确性、可靠性、完整性和及时性做出任何承诺和保证。若有疑问,可以通过电子邮件方式联系我们:report@aminer.cn